Crescent Biopharma awarded stock options for 11,775 shares to a new non-executive employee as part of an inducement plan approved by its Compensation Committee. The options have a 10-year term with an exercise price of $12.91, matching the closing share price on November 2, 2026. Vesting occurs over four years, starting one year after employment begins. This move aims to attract talent to support Crescent's development of innovative cancer therapies.
Crescent Biopharma's inducement awards provide context for health-sector trading activity on Pluang as of Nov 04, 2026 04:11 WIB. Among 150 priced US health stocks, 92 rose and 55 fell. Notably, IOVA rose 10.47% to USD 8.86 but saw 99% sell orders, contrasting with ABCL which gained 8.90% to USD 12.11 alongside 100% buy orders and a longer typical hold time of 42 days. DNA also increased 9.04% to USD 10.74 with a more balanced order activity of 67% sell and 33% buy.
Vencora has acquired CT InsureTech, a leading insurance technology provider with offices in London, Buenos Aires, and Mexico City. This acquisition strengthens Vencora's insurance technology offerings and expands its presence in Latin America and Eur...
Vencora has acquired CT InsureTech, a leading provider of insurance technology and services with offices in London, Buenos Aires, and Mexico City. This acquisition expands Vencora's portfolio and presence in Latin America and the UK, strengthening it...
HP Inc. will announce its financial results for the fourth quarter and full fiscal year ending October 31, 2026, on November 24, 2026, via a live webcast. The company will also participate in several investor conferences in December, including UBS Gl...
Fuel Tech, Inc. reported a 16% increase in third-quarter 2026 revenues to $8.7 million, driven by strong demand in its Air Pollution Control segment and a growing backlog. Despite higher sales, the company posted a net loss of $267,000 due to margin ...
Dover Corporation announced that its CEO, Richard J. Tobin, will present at the Baird 2026 Global Industrial Conference in Chicago on November 10, 2026. The presentation will be webcast live and available for replay on Dover's website for 90 days. Do...
